Cutillas, V., Mesplede, T., Anstett, K., Hassounah, S., & Wainberg, M. A. (2014). The R262K Substitution Combined with H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir. Antimicrob Agents Chemother.
Παραπομπή Chicago StyleCutillas, Vincent, Thibault Mesplede, Kaitlin Anstett, Said Hassounah, και Mark A. Wainberg. "The R262K Substitution Combined With H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir." Antimicrob Agents Chemother 2014.
Παραπομπή MLACutillas, Vincent, et al. "The R262K Substitution Combined With H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir." Antimicrob Agents Chemother 2014.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.